SIA A2Z PharmaActive
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 318 001 € (40% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2018–2025
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||
| Total current assets | 139 | 79 255 | 63 800 | 270 708 | 626 202 | 728 972 | 967 975 | 1 408 194 |
| Total non-current assets | 0 | 0 | 8540 | 5521 | 8817 | 45 018 | 87 002 | 80 443 |
| Total assets | 139 | 79 255 | 72 340 | 276 229 | 635 019 | 773 990 | 1 054 977 | 1 488 637 |
| Balance sheet — liabilities and equity | ||||||||
| Current liabilities | 3018 | 1440 | 9465 | 17 310 | 8813 | 47 290 | 267 761 | 330 616 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 6458 | 0 | 0 |
| Total liabilities | 3018 | 1440 | 9465 | 17 310 | 8813 | 53 748 | 267 761 | 330 616 |
| Share capital | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — |
| Profit for the year | -2882 | 80 694 | -14 940 | 234 444 | 435 686 | 230 036 | 392 974 | 688 806 |
| Total equity | -2879 | 77 815 | 62 875 | 258 919 | 626 206 | 720 242 | 787 216 | 1 158 021 |
| Income statement | ||||||||
| Sales revenue | 0 | 468 298 | 446 734 | 8 082 769 | 11 505 939 | 15 136 182 | 13 441 019 | 12 254 836 |
| Operating profit | -2882 | 80 694 | -14 940 | 244 044 | 453 053 | 265 331 | 475 325 | 769 747 |
| Profit before income tax | -2882 | 80 694 | -14 940 | 244 044 | 453 053 | 264 593 | 474 474 | 769 556 |
| Profit for the reporting year | -2882 | 80 694 | -14 940 | 234 444 | 435 686 | 230 036 | 392 974 | 688 806 |
| Labour costs | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||
| Employees | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 4 |
| Calculated dividend | — | 0 | 0 | 38 400 | 68 399 | 136 000 | 326 000 | 318 001 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA A2Z Pharma
Overview
SIA A2Z Pharma (reg. no. 40203154278) is a limited liability company. The company was registered in 2018 and has been in the register for 8 years. Registered address: Rīga, Augļu iela 11 - 14.
Financial results
Revenue in 2025 was 12 254 836 €, down 8,8% on the previous year (13 441 019 €). Net profit for 2025 was 688 806 € (5,6% of revenue). The company was profitable in 6 of the 8 published years. In 2025 the company had 4 employees. Revenue per employee was 3 063 709 €. At the end of 2025, total assets were 1 488 637 € and equity 1 158 021 € (77,8% of assets).
Management and owners
The board has 2 members. According to the register, the company has 2 owners. The largest stake (50%) is held by a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.